-+ 0.00%
-+ 0.00%
-+ 0.00%

KYMERA THERAPEUTICS TO ANNOUNCE KT-621 BROADEN2 PHASE 2B ATOPIC DERMATITIS TRIAL RESULTS ON NOVEMBER 23, 2026

Reuters·11/20/2026 21:01:00

Please log in to view news